The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working GroupKhalid El Bairi, John M.S. Bartlett, Harry R. Haynes et al.|npj Breast Cancer|2021Cited by 282
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancerZuzana Kos, Yinyin Yuan, Elvire Roblin et al.|npj Breast Cancer|2020Cited by 208
Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancersDominik Głodzik, Johan Staaf, Ana Bosch et al.|Nature Communications|2020Cited by 141
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancerJohan Staaf, Johan Vallon‐Christersson, Martin Malmberg et al.|npj Breast Cancer|2022Cited by 103
Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiativeLisa Rydén, Åke Borg, Niklas Loman et al.|British journal of surgery|2018Cited by 64